Understanding Microbial keratitis and corneal ulcers
An ulcer is an area of corneal surface breakdown, often with deeper inflammation. Bacteria, fungi and Acanthamoeba require different medicines; herpes is another infectious pathway discussed separately. Contact lenses, injury and pre-existing surface disease are important contexts, with their relative importance varying by region. [1] [2]
Severity depends on organism, size, depth, location and response to treatment. Some infections heal with limited scarring, while central scarring, thinning or perforation can threaten useful vision. A small-looking lesion is not automatically safe to monitor at home. [1] [2]
One condition. Different experiences.
Explore different selected symptom features, then read how they may vary. These examples are not stages or a clinical test.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.
Pain, redness and light sensitivity
Discomfort can range from irritation to severe pain, with tearing and difficulty tolerating light. Pain intensity alone cannot reliably identify the organism or rule infection out. [1] [3]
Blur and glare
Surface disruption, inflammation and later scarring can reduce detail or scatter light. A uniform blur example cannot reproduce the location of an ulcer or distinguish active infection from a healed scar. [1] [2]
A demanding recovery
Frequent drops, repeat examinations and sometimes a long course can disrupt sleep, work and caring duties. Acanthamoeba treatment in particular may be prolonged, and practical support is part of care. [1] [3]
Different organisms, different treatment pathways
Original schematic; no culture result or individual course is inferred from a simulated appearance. [1] [2] [3]
Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.- Surface vulnerability
Lenses, trauma or surface disease can create an entry opportunity.
- Identify and treat
Examination and selected sampling guide organism-appropriate care.
- Assess recovery
Healing, scar location and useful vision require separate follow-up.
What is happening—and what remains uncertain
The intact corneal surface normally protects deeper tissue. A damaged surface, contaminated lens or other vulnerability can allow microbes to invade, causing inflammation and tissue damage. A fungal injury after vegetation exposure and a water-associated lens infection illustrate different pathways, not guaranteed diagnoses. [2] [3] [8]
Treatment aims to control the organism before damage progresses, while managing the inflammatory response safely. Steroids can be appropriate in selected specialist-managed circumstances but can worsen some infections or mask progression. They are not a general first response to an undiagnosed red eye. [2] [4]
What can look similar?
Sterile marginal inflammation
Marginal keratitis often reflects an immune response associated with eyelid disease. It can resemble infection, especially with epithelial breakdown, so a past diagnosis does not justify self-starting steroid drops for a new episode. [2]
Herpes and recurrent epithelial disease
Herpes infection can involve different corneal layers and has its own antiviral and anti-inflammatory decisions. A bacterial-antibiotic trial does not establish the best care for herpetic disease. [2]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- Examine the cornea and anterior eyeThe clinician records acuity, surface staining, infiltrate size and depth, and signs of thinning or inflammation inside the eye. Bring the lens and case if the clinic requests them, but do not reinsert the lens. [1] [2]
- Explain the exposure historyReport lens sleeping, swimming or showering, recent injury, gardening, prior herpes, steroids and immune-related health problems. This history helps select testing and treatment without proving which organism is responsible. [2] [3] [8]
- Sampling and targeted testingSelected ulcers need a corneal scrape for microscopy and culture. Confocal imaging or molecular tests may help investigate Acanthamoeba or other difficult cases. Negative sampling does not automatically exclude infection, and the examination may determine urgent initial treatment. [2] [3]
What may help—and what is still being studied
Organism-directed medicines
Bacterial disease generally requires topical antibiotics; fungal and Acanthamoeba disease need different agents. Initial intensive treatment is adjusted using the clinical course and laboratory information. Ask for a written schedule and help obtaining medicines rather than improvising with leftover drops. [1] [2] [3]
Adjuncts need evidence and supervision
The 2025 SCUT II trial did not show average superiority of its steroid adjunct, and cross-linking increased scar size. This does not make all clinical steroid decisions identical, but it argues against marketing an adjunct as a universal shortcut to healing. [4]
Advanced disease and access
Threatened perforation or uncontrolled infection may require surgical measures, sometimes including a corneal transplant. For Acanthamoeba, an EU-authorized polihexanide product now exists; authorization and local access differ, and trial results do not support home preparation or universal treatment success. [2] [3] [6] [7]
What this can mean for daily life
Make the drop plan usable
Ask the team to explain spacing, night-time requirements, storage and what to do about a missed dose. Alarms, a written chart or help from a supporter can make an intensive regimen practical. [1] [3]
Protect lenses from water
When lens wear is eventually cleared, follow disinfection and replacement instructions, keep lenses away from water and carry backup glasses. Never use tap water or saliva to rinse or store lenses; avoid topping up old solution. [8]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
SCUT II: steroids and cross-linking for bacterial ulcers
The steroid strategy was not superior on average; added cross-linking increased scar size, without a demonstrated overall advantage over the antibiotic control. [4]
Limits and applicability: Applies to the enrolled bacterial-ulcer population and specified adjuncts, not fungal, Acanthamoeba or herpes disease. Failure to prove superiority is not proof of identical outcomes for every subgroup.
Mycotic Ulcer Treatment Trial I
Natamycin produced better three-month acuity and fewer perforation/transplant events overall; much of the difference involved Fusarium. [5]
Limits and applicability: Specific fungal population, largely treated in South India, with early recruitment stopping. Results cannot simply rank treatment for all fungi or all corneal infections.
ODAK phase 3 trial
The specified polihexanide monotherapy met the predefined noninferiority criterion versus a dual regimen for medical cure under the trial protocol. [6]
Limits and applicability: Not superiority, not a cure guarantee and not proof that every compounded formulation or disease severity performs similarly. Treatment delivery and eligibility matter.
Questions researchers still need to answer
- Which rapid diagnostic pathways improve organism identification without delaying effective initial treatment?
- Which adjuncts improve meaningful vision and reduce scarring for well-defined organisms and severities?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
Moorfields — microbial keratitis
Explains urgent care, treatment intensity and follow-up.
Moorfields — Acanthamoeba keratitis and support
Detailed disease information with counseling and liaison routes for hospital patients; access to services is local.
CDC — healthy contact-lens habits
Practical prevention, lens hygiene and backup-glasses guidance.
Dry Eye Foundation — ocular-surface community
Broader practical and emotional support for persistent ocular-surface problems, not an emergency infection service or dedicated organism-specific group.
Connections listed by the organization.
Questions you may still have
Can I wait until a white spot gets larger?
No. A painful red eye or visual change needs urgent assessment; the apparent size at home does not reliably indicate risk. [1] [2]
Do all corneal infections use antibiotic drops?
No. Fungal and Acanthamoeba infections require different treatment, and herpes has a separate pathway. The examination, exposures and testing help choose appropriate medicine. [2] [3]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- Moorfields — Microbial Keratitis (n.d.; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked - Rhee et al., AAO — Bacterial Keratitis Preferred Practice Pattern (2024; guideline).
Indexed clinical recommendations read; direct publisher client 403. Bacterial scope, not a substitute for organism-specific fungal/amoebic evidence.
Checked 2026-10-24 · Full text checked - Moorfields — Acanthamoeba keratitis (n.d.; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked - Prajna et al. — SCUT II randomized clinical trial (2025; trial).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Prajna et al. — Mycotic Ulcer Treatment Trial I (2013; trial).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - Dart et al. — ODAK trial (2024; trial).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - European Medicines Agency — Akantior (2024; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked - CDC — Preventing Eye Infections When Wearing Contacts (2025; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked - Dry Eye Foundation — You are not alone (n.d.; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.